Skip to main content

Advertisement

Log in

Slug signaling is up-regulated by CCL21/CXCR7 to induce EMT in human chondrosarcoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 06 February 2015

Abstract

In recent decades, the CXC chemokine receptor 7 (CXCR7) and its ligand CCL21 have been extensively reported to be associated with tumorigenesis. Meanwhile, Slug signaling induces the epithelial-mesenchymal transition (EMT) process in chondrosarcoma development. In the present study, we explored the functions of CCL21/CXCR7 in Slug-mediated EMT in the chondrosarcoma. We analyzed protein expression of CXCR7 and Slug in human chondrosarcoma samples. Effects of CXCR7 on chondrosarcoma cells were assessed by in vitro assays. Additionally, CXCR7 pathways were further investigated by pharmacological and genetic approaches. We found that the altered CXCR7 (81.7 %) and Slug (85.0 %) expression in human chondrosarcoma tissues were significantly associated with grade, recurrence, and 5-year overall survival. According to in vitro assays, CCL21 stimulation induced the expression of phosph-ERK, phosph-AKT, Slug and N-cadherin in SW1353 cells, while the expression of E-cadherin was down-regulated. Furthermore, Slug signaling modulated E- to N-cadherin switch, which was influenced by the kinase inhibitor PD98059 and LY294002. In addition, the genetic silencing of Slug inhibited the capacity of migration and invasion of SW1353 cells. In conclusion, CCL21/CXCR7 pathway activates ERK and PI3K/AKT signallings to up-regulate Slug pathway, leading to the occurrence of EMT process in human chondrosarcoma. This study lays a new foundation for molecule-targeted therapy of human chondrosarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Randall RL, Bruckner J, Lloyd C, et al. Sacral resection and reconstruction for tumors and tumor-like conditions. Orthopedics. 2005;28:307–13.

    PubMed  Google Scholar 

  2. Bergh P, Gunterberg B, Meis-Kindblom JM, et al. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer. 2001;91:1201–12.

    Article  CAS  PubMed  Google Scholar 

  3. Bovée JV, Cleton-Jansen AM, Taminiau AH, et al. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol. 2005;6:599–607.

    Article  PubMed  Google Scholar 

  4. Tan ML, Shao P, Friedhuber AM, et al. The potential role of free chitosan in bone trauma and bone cancer management. Biomaterials. 2014;35:7828–38.

    Article  CAS  PubMed  Google Scholar 

  5. Uchida A, Seto M, Hashimoto N, et al. Molecular diagnosis and gene therapy in musculoskeletal tumors. J Orthop Sci. 2000;5:418–23.

    CAS  PubMed  Google Scholar 

  6. Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320–9.

    Article  PubMed  Google Scholar 

  7. Ishikawa T, Shimizu T, Ueki A, et al. Twist2 functions as a tumor suppressor in murine osteosarcoma cells. Cancer Sci. 2013;104:880–8.

    Article  CAS  PubMed  Google Scholar 

  8. Casas E, Kim J, Bendesky A, et al. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 2011;71:245–54.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7:re8.

    Article  PubMed  Google Scholar 

  10. Tirino V, Camerlingo R, Bifulco K, et al. TGF-beta1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Cell Death Dis. 2013;4:e620.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Eberlein C, Rooney C, Ross SJ, et al. E-cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin alphavbeta6 and maintained through TGF beta signalling. Oncogene. 2014. doi:10.1038/onc.2013.600.

    PubMed  Google Scholar 

  12. Liu RY, Zeng Y, Lei Z, et al. JAK/STAT3 signaling is required for TGF-beta-induced epithelial-mesenchymal transition in lung cancer cells. Int J Oncol. 2014;44:1643–51.

    CAS  PubMed  Google Scholar 

  13. Jing Y, Han Z, Zhang S, et al. Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci. 2011;1:29.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Zheng H, Kang Y. Multilayer control of the EMT master regulators. Oncogene. 2014;33:1755–63.

    Article  CAS  PubMed  Google Scholar 

  15. Nieto MA, Sargent MG, Wilkinson DG, et al. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science. 1994;264:835–59.

    Article  CAS  PubMed  Google Scholar 

  16. Haupt S, Alsheich-Bartok O, Haupt Y. Clues from worms: a Slug at Puma promotes the survival of blood progenitors. Cell Death Differ. 2006;13:913–5.

    Article  CAS  PubMed  Google Scholar 

  17. Umar S. Enteric pathogens and cellular transformation: bridging the gaps. Oncotarget. 2014;5:6573–5.

    PubMed Central  PubMed  Google Scholar 

  18. Ding W, You H, Dang H, et al. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology. 2010;52:945–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Cicchini C, Laudadio I, Citarella F, et al. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res. 2008;314:143–52.

    Article  CAS  PubMed  Google Scholar 

  20. Leckband D. Beyond structure: mechanism and dynamics of intercellular adhesion. Biochem Soc Trans. 2008;36:213–20.

    Article  CAS  PubMed  Google Scholar 

  21. Hsu YL, Hou MF, Kuo PL, et al. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013;32:4436–47.

    Article  CAS  PubMed  Google Scholar 

  22. Li Y, Jia L, Ren D, et al. Axl mediates tumor invasion and chemosensitivity through PI3K/Akt signaling pathway and is transcriptionally regulated by slug in breast carcinoma. IUBMB Life. 2014;66:507–18.

    Article  CAS  PubMed  Google Scholar 

  23. Suman S, Kurisetty V, Das TP, et al. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells. Mol Carcinog. 2014;53:E151–60.

    Article  CAS  PubMed  Google Scholar 

  24. Li Y, Zhao Z, Xu C, et al. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Cancer Lett. 2014;355:130–40.

    Article  CAS  PubMed  Google Scholar 

  25. He LC, Gao FH, Xu HZ, et al. Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma cells. Oncol Rep. 2012;28:1399–405.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully thank Mingtang He and Ziqing Zhang for their critical reading of this paper and valuable suggestions.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ziqing Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, G., Yang, Y., Xu, S. et al. Slug signaling is up-regulated by CCL21/CXCR7 to induce EMT in human chondrosarcoma. Med Oncol 32, 2 (2015). https://doi.org/10.1007/s12032-014-0478-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0478-6

Keywords

Navigation